Does SECUKINUMAB Cause Product supply issue? 357 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 357 reports of Product supply issue have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.2% of all adverse event reports for SECUKINUMAB.
357
Reports of Product supply issue with SECUKINUMAB
0.2%
of all SECUKINUMAB reports
4
Deaths
50
Hospitalizations
How Dangerous Is Product supply issue From SECUKINUMAB?
Of the 357 reports, 4 (1.1%) resulted in death, 50 (14.0%) required hospitalization, and 6 (1.7%) were considered life-threatening.
Is Product supply issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 357 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Product supply issue?
LENALIDOMIDE (310)
CANNABIDIOL (298)
APREMILAST (266)
HUMAN IMMUNOGLOBULIN G (169)
OFATUMUMAB (149)
ELTROMBOPAG OLAMINE (140)
HUMAN C1-ESTERASE INHIBITOR (117)
OXCARBAZEPINE (109)
CARBAMAZEPINE (98)
POMALIDOMIDE (92)
Which SECUKINUMAB Alternatives Have Lower Product supply issue Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG